3. Duplicative Therapy
Combined use of two or more ACIs does not provide enhanced therapeutic benefit and may result in additive adverse effects. Concurrent administration of two or more ACIs is not recommended and will be reviewed.
Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.